ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $22,000 | +57.1% | 500 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $14,000 | -61.1% | 500 | -90.0% | 0.00% | -70.0% |
| Q1 2018 | $36,000 | +100.0% | 5,000 | 0.0% | 0.01% | +100.0% |
| Q4 2017 | $18,000 | -58.1% | 5,000 | -50.0% | 0.01% | -61.5% |
| Q3 2017 | $43,000 | +152.9% | 10,000 | 0.0% | 0.01% | +160.0% |
| Q2 2017 | $17,000 | -10.5% | 10,000 | 0.0% | 0.01% | -28.6% |
| Q1 2017 | $19,000 | -20.8% | 10,000 | -33.3% | 0.01% | -22.2% |
| Q4 2016 | $24,000 | -78.2% | 15,000 | 0.0% | 0.01% | -80.9% |
| Q3 2016 | $110,000 | +2.8% | 15,000 | -25.0% | 0.05% | +4.4% |
| Q2 2016 | $107,000 | – | 20,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |